Remicade "Reduces" Arthritis Progression; "Prevention" Not Clearly Defined
Executive Summary
Centocor's Remicade data support a claim in the reduction of rheumatoid arthritis progression, but a claim for "prevention" needs further definition, FDA's Arthritis Drugs Advisory Committee said at its July 12 meeting.